AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
LANDON, GREATER LANDON, UNITED KINGDOM, November 6, 2024 /EINPresswire.com/ -- The Business Research Company’s Early Year-End Sale! Get up to 30% off detailed market research reports—limited time only!
The meningococcal vaccines market has experienced significant growth in recent years, projected to rise from $3.57 billion in 2023 to $3.94 billion in 2024, reflecting a compound annual growth rate (CAGR) of 10.5%. Factors contributing to this growth during the historical period include the incidence of disease, global travel trends, advancements in healthcare infrastructure, epidemic preparedness, and increased health insurance coverage.
What Is the Estimated Growth Rate and Market Size of the Global Meningococcal Vaccines Market?
The meningococcal vaccines market is projected to experience robust growth in the coming years, expected to reach $5.69 billion by 2028, with a compound annual growth rate (CAGR) of 9.6%. This growth during the forecast period can be attributed to the emergence of new strains, increasing globalization, rising healthcare investments, health initiatives, and a changing regulatory landscape.
Access Key Market Data and Trends with a Free Sample Report on the Global Meningococcal Vaccines Market:
https://www.thebusinessresearchcompany.com/sample_request?id=8013&type=smp
What Are The Significant Drivers Behind The Growth Of The Meningococcal Vaccines Market?
An increase in healthcare spending is anticipated to drive the growth of the meningococcal vaccine market in the future. Healthcare encompasses various facilities, including residential care institutions, nursing homes, and intermediate care facilities for individuals with mental illnesses or intellectual disabilities. The higher costs associated with new generations of vaccines, compared to earlier versions, have sparked discussions regarding whether the benefits of these new vaccines justify their price tags. Evaluating the overall social and economic benefits of vaccination is becoming an increasingly significant focus in the literature surrounding the valuation of vaccines.
Pre-book the report for a swift delivery:
https://www.thebusinessresearchcompany.com/report/meningococcal-vaccines-global-market-report
Which Top Companies Are Shaping The Growth Of The Meningococcal Vaccines Market?
Key players in the meningococcal vaccines market include Pfizer Inc., Johnson and Johnson Services Inc., Sinopharm Group Co Ltd., Merck & CoInc., Novartis AG, Sanofi S.A, AstraZeneca plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Limited, Seqirus Pty Ltd., Sinovac Biotech Ltd., Emergent BioSolutions Inc., Walvax Biotechnology Co Ltd., Hualan Biological Engineering Inc.,
Which Emerging Trends Are Reshaping the Meningococcal Vaccines Market Size?
Leading companies in the meningococcal vaccines market are prioritizing partnerships to enhance their profitability. These collaborations involve pharmaceutical companies, research institutions, government agencies, and non-profit organizations working together to advance the development, production, distribution, or improvement of meningococcal vaccines.
What Are The Segments In The Global Meningococcal Vaccines Market?
1) By Vaccine Type: Meningococcal Conjugate Vaccine, Polysaccharide, Subcapsular Vaccine
2) By Serotype: Men Acwy, Men B/Bc, Men C
3) By Age Group: Infants, Children, Adolescents and Young Adults, Adults
4) By Distribution Channel:: Pharmacies, Community Clinics, Public Health Agencies, Other Channels
5) By End user: Hospitals, Research, Academic Institutes
North America: Largest Region in the Meningococcal Vaccines Market
North America was the largest region in the market in 2023. Asia-Pacific is expected to be the fastest-growing region in the report during the forecast period. The regions covered in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Is The Meningococcal Vaccines Market Defined?
Meningococcal vaccinations are designed to protect against meningococcal meningitis, an infection caused by the bacterium *Neisseria meningitidis*, which results in inflammation of the tissues surrounding the brain and spinal cord.
The Meningococcal Vaccines Global Market Report 2024 from The Business Research Company includes the following key information:
• Market size data for both historical and future periods
• Analysis of both macro and microeconomic factors that have impacted the market over the past five years
• Regional market analysis covering Asia-Pacific, China, Western Europe, Eastern Europe, North America, the USA, South America, and the Middle East and Africa
• Country-specific market analysis for Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.
Overview of the Global Meningococcal Vaccines Market Report: Trends, Opportunities, Strategies, and More
The Meningococcal Vaccines Global Market Report 2024 from The Business Research Company is an extensive resource that delivers insights into meningococcal vaccines market size, meningococcal vaccines market drivers and trends, meningococcal vaccines competitors' revenues, and meningococcal vaccines market growth across geographies. This report provides valuable in-depth insights into potential opportunities and strategies. Companies can utilize the information presented to target segments with the greatest growth potential.
Browse Through More Similar Reports By The Business Research Company:
Cancer Vaccines Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report
DTP Vaccines Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/dtp-vaccine-global-market-report
Pediatric Vaccine Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report
What Services Does The Business Research Company Offer?
The Business Research Company has published more than 15,000 reports spanning 27 industries and over 60 regions. Our research is supported by 1.5 million datasets, thorough secondary research, and unique insights gained from interviews with industry experts. We offer ongoing and customized research services, featuring a variety of specialized packages designed to meet your specific needs, such as Market Entry Research, Competitor Tracking, Supplier & Distributor Packages, and many others.
Our flagship product, the Global Market Model, serves as a leading market intelligence platform that provides comprehensive and updated forecasts to facilitate informed decision-making.
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
X
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
